Tested positive, have risk factors? There soon may be a pill for that
This undated image provided by Merck & Co. shows its new antiviral medication. Pharmaceutical company Merck & Co. said Friday, Oct. 1, 2021, that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use. (Merck & Co. via AP)
Think of it as Tamiflu for COVID.
Topics
Antivirals COVID 19Jane Roberts
Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers business news and features for The Daily Memphian.
Want to comment on our stories? Or read the comments of others? Join the conversation by subscribing now. Only subscribers can view or add comments. Our commenting policy can be viewed here.